DSIP

Delta Sleep-Inducing Peptide

A naturally occurring neuropeptide that promotes deep restorative sleep and modulates stress hormone responses.

100% 50% · t½ Time → Serum level
Molecular Weight 848.8 Da
Half-Life ~30 minutes
Typical Dose 100–300 mcg
Cycle Length 2–4 weeks

Description

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated in 1977 from the cerebral venous blood of rabbits by Monnier and colleagues at the University of Basel. It is found endogenously in the hypothalamus, pituitary, and limbic system, as well as in peripheral tissues including the adrenal gland and gut. DSIP promotes slow-wave (delta) sleep, reduces stress-induced ACTH and cortisol release, has demonstrated analgesic properties, and exhibits antioxidant activity. Research has also explored its potential in managing withdrawal symptoms from alcohol and opioids, and in reducing pain in chronic pain syndromes. Its amphiphilic structure allows it to cross the blood-brain barrier, which is unusual for a peptide of its size.

 

Key Characteristics

Molecular Formula

C35H48N10O15

Molecular Formula

848.8 Da

Half-Life

~30 minutes

Administration Routes

Subcutaneous injection, Intranasal

Typical Dose

100–300 mcg

Frequency

Before bed

Investigated Benefits

* Benefits based on preclinical/animal research unless otherwise noted.

Mechanism of Action

“A naturally occurring neuropeptide that promotes deep restorative sleep and modulates stress hormone responses.”

DSIP modulates the hypothalamic-pituitary-adrenal (HPA) axis by reducing the release of ACTH from the anterior pituitary and subsequently lowering cortisol secretion under stress conditions. Its sleep-promoting effects are mediated through modulation of GABAergic neurotransmission — enhancing the inhibitory tone that promotes slow-wave sleep — as well as through serotonergic pathways. DSIP also appears to inhibit somatostatin (growth hormone-inhibiting hormone) release, which may contribute to nocturnal GH secretion during deep sleep. Its antioxidant properties involve scavenging of reactive oxygen species (ROS) and upregulation of endogenous antioxidant enzymes. At the cellular level, DSIP has been shown to modulate mitochondrial function and reduce oxidative damage, which may underlie its reported neuroprotective effects.

Administration Routes

Subcutaneous injection

Intranasal

Key Characteristics

Typical Dose

100–300 mcg

Frequency

Before bed

Cycle Length

2–4 weeks

Administration

Subcutaneous injection

Protocol Notes

Administer 30–60 minutes before sleep. Can be used nightly or as needed. Some users report vivid dreams initially.

 

Reconstitution Guide

Add 2 mL bacteriostatic water to 2 mg vial → 1000 mcg/mL For 200 mcg dose: draw 0.2 mL (20 units on U-100 syringe)

Storage Information

Lyophilized: refrigerate. Reconstituted: refrigerate and use within 14 days.

Quality & Sourcing Standards

When sourcing DSIP for research purposes, the following quality benchmarks should be verified before use.

Purity:

>98% (verified by HPLC)

Certificate of Analysis (COA):

Must be provided by supplier

Endotoxin Testing:

<0.1 EU/mg (prevents bacterial contamination)

GMP Compliance:

Manufactured in cGMP-certified facility

Third-Party Testing:

Independent lab verification preferred

Storage Information

Lyophilized: refrigerate. Reconstituted: refrigerate and use within 14 days.

FDA Disclaimer

The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.

Research Highlights

1

Demonstrated delta-wave sleep induction in multiple animal models

2

Reduced ACTH secretion in stress models

3

Analgesic effects in rat models

Evidence Level

Primarily animal studies with limited human data. Mechanism is plausible but clinical efficacy is unconfirmed.

Compatible Peptides

Peptides commonly used alongside DSIP for synergistic effects.

Epithalon

A tetrapeptide derived from the pineal gland that activates telomerase and has demonstrated lifespan extension in multiple animal models.

Selank

A Russian-developed anxiolytic peptide with nootropic properties that reduces anxiety without sedation or dependence.

Quick Reference

Category

Cognitive & Neuro
 

Status

Research Only
 

Dose

100–300 mcg
 

Frequency

Before bed
 

Cycle

2–4 weeks